Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 44Neoplasm Metastasis 19Liver Neoplasms 18Colorectal Neoplasms 15Cholangiocarcinoma 11Pancreatic Neoplasms 9Lung Neoplasms 9Colonic Neoplasms 9Breast Neoplasms 8Carcinoma, Renal Cell 7Carcinoma, Non-Small-Cell Lung 7Barrett Esophagus 7Thyroid Nodule 6Recurrence 6Rectal Neoplasms 6Thyroid Neoplasms 5Pain 4Neoplasms 4Kidney Neoplasms 4Esophageal Neoplasms 4Thyroid Cancer, Papillary 3Prostatic Neoplasms 3Leiomyoma 3Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Agnosia 3Thyroid Diseases 2Hyperaldosteronism 2Hepatitis B 2Gallbladder Neoplasms 2

Interventions

Gemcitabine 5130-nm albumin-bound paclitaxel 3nimotuzumab 2Oxaliplatin 2Leucovorin 2Irinotecan 2Hematologic Tests 2Fluorouracil 2Albumin-Bound Paclitaxel 2surufatinib 1napabucasin 1irinotecan sucrosofate 1ensituximab 1Taxes 1S 1 (combination) 1Radiofrequency Ablation 1Paclitaxel 1Mass Screening 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic cancer, adult × Radiofrequency Ablation × Clear all
NCT03152487 2019-02-11

Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis

AdventHealth

Phase NA Completed
28 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡